Question 1

What is Aptose Biosciences?

Accepted Answer

Aptose Biosciences is a Company.

Question 2

How often does Aptose Biosciences appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Aptose Biosciences first tracked by Ergen?

Accepted Answer

First tracked on Jun 30, 2026.

Question 4

When was Aptose Biosciences last mentioned in news?

Accepted Answer

Last active on Jun 30, 2026.

Question 5

What is Aptose Biosciences's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Aptose Biosciences in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Aptose Biosciences?

Accepted Answer

Hanmi acquires Aptose Biosciences (Jun 30, 2026, 6 articles).

Question 8

How did the "Hanmi acquires Aptose Biosciences" event impact Aptose Biosciences?

Accepted Answer

Aptose Biosciences was acquired by Hanmi Pharm for C$2.41 per share, representing a 28% premium. Its common shares are expected to be delisted from the Toronto Stock Exchange.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.